Investigations on the stereoselective action of isoxsuprine on α- and β-adrenoceptors in equine common digital artery

Pharmacological Research

Volumn 40, Issue 2, 1999, Pages 177-182

  Belloli, Chiara ^a   Badino, Paola ^b   Carcano, Roberta ^c   Odore, Rosangela ^b   Arioli, Francesco ^c   Caloni, Francesca ^c   Giovanni, R E ^b  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Drug chirality; Equine common digital artery; Isoxsuprine; and adrenoceptors

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ISOXSUPRINE; NORADRENALIN; PRAZOSIN; PROPRANOLOL DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CHIRALITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIGITAL ARTERY; DRUG POTENCY; ENANTIOMER; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; RADIOASSAY; SCATCHARD PLOT; SMOOTH MUSCLE; STEREOCHEMISTRY;

EID: 0032796930     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1999.0487     Document Type: Article

References (29)

1. Kenakin T. Pharmacologie analysis of drug-receptor interaction. 3rd ed. Philadelphia, New York: Lippincott-Raven Publishers, 1997.
2. Ariens EJ. Chirality in bioactive agents and its pitfall. TIPS 1986; 7: 200-5.
3. Ruffolo RR Jr, Spradlin TA, Pollock GD, Waddell JE, Murphy PJ. α- and β-adrenergic effects of the stereoisomers of dobutamine. J Pharmacol Exp Ther 1981; 219: 447-52.
4. Stauber RE, Heinemann A. Propranolol stereoselectivity inhibits αadrenoceptor-mediated vasoconstriction in mesenteric arterial beds of rats. J Anton Pharmacol 1996; 16: 125-9.
5. Reynolds JEF. Martindale -the extra pharmα copoeia. 31st ed. London: The Pharmaceutical Press, 1996.
6. Ariens EJ, Waelen NJGA, Sonneville PF, Simonis AM. The pharmacology of catecholamines and their derivatives. Arzneim-Forsch 1963; 13: 541-6.
7. Deumer J, de Haan F, Tulp MThM, van den Hoven R. Effect of an isoxsuprine-resin preparation on bloodflow in the equine thoracic limb. Vet Record 1991; 129: 427-9.
8. Rose RJ, Alien JR, Hodgson DR, Kohnke JR. Studies on isoxsuprine hydrochloride for the treatment of navicular disease. Equine Vet J 1983; 15: 238-43.
9. Turner SA, Tucker CM. The evaluation of isoxsuprine hydrochloride for the treatment of navicular disease: a double blind study. Equine Vet J 1989; 21: 338-41.
10. 2 receptor mechanisms in rats jugular veins: differences between norepinephrine and isoproterenol-induced relaxation. Life Sei 1978; 23: 1997-2006.
11. Farrar DB, Verity A. Analysis of the effects of isoxsuprine on guinea pig atria and trachea. Br J Pharmacol 1976; 53: 431-2.
12. Abel PW, Fox AW, Minnerman KP. Effects of isoxsuprine and nylidrin on adrenoceptors in rat vas deferens. J Auton Pharmacol 1985; 5: 213-19.
13. Calixto JB, Simas CM. Mechanism of action of isoprenaline, isoxsuprine, terbutaline and orciprenaline on gravid human isolated myometrium. Influence of the neuronal uptake process. Biol Reprod 1984; 30: 1117-23.
14. Elliot J, Soydan J. Characterization of β-adrenoceptors in equine digital veins: implications of the modes of vasodilatory action of isoxsuprine. Equine Vet J (supp) 1995; 19: 101-7.
15. Marteau P, Ballet F, ChrEtien Y, Rey C, Jaillou P, Poupon R. Effect of vasodilators on hepatic microcirculation: a study of the inhibition of norepinephrineinduced vasoconstriction in the isolated perfused rat liver. Hepatology 1988; 8: 228-31.
16. 2-adrenoceptor stimulant. Jpn J Pharmacol 1984; 36: 477-84.
17. Kanjanapone V, Puri A. Effects of isoxsuprine on β-adrenergic receptors and adenylate cyclase in fetal rabbit cardiac membranes. Pediatric Res 1981; 15: 338.
18. van Dijk J, Moed HD. Synthesis of β-phenylethylamine derivatives VII. Recueil des Travaux Chimiques des Pays-Bas 1961; 80: 573-87.
19. Lowry OH, Rosenbrough NH, Farr AL, Randall RJ. Protein measurement with the Polin phenol reagent. J Biol Chem 1951; 193: 265-75.
20. Lemoine H. β-Adrenoceptor ligands: characterization and quantification of drug effects. Quant Struct Act Rel 1992; 11: 211-18.
21. Re G, Belloli C, Badino P, Arioli F, Novelli A, Girardi C, Beretta C. Identification of β-adrenoceptor subtypes mediating relaxation in horse isolated ileum. Am J Vet Res 1997; 58: 621-5.
22. 2-adrenergic receptor gene in pregnant rat myometrium. J Biol Chem 1992; 267: 7975-8.
23. 2-adrenoceptors in isolated swine myometrium. J Anton Pharmacol 1995; 15: 93-105.
24. Scatchard G. The attraction of proteins for small molecules and ions. Ann NY Acad Sei 1949; 51: 660-9.
25. Cheng YC, Prusoff WH. Relationship between the inhibition constant (K() and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 1973; 2: 3099-108.
26. Ruffolo RR Jr, Bondinell W, Hieble JP. α- and β-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications. J Med Chem 1995; 38: 3681-716.
27. Brittain RT, Drew GM, Levy GP. The α and β-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anesthetized dogs in isolated tissues. Br J Pharmacol 1982; 77: 105-14.
28. Riva E, Mennini T, Latini R. The α- and β-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers. Br J Pharmacol 1991; 104: 823-8.
29. Ruffolo RR Jr, Goldberg MR, Morgan EL. Interaction of epinephrine, norepinephrine, dopamine and their corresponding αmethyl-substituted derivatives with α and β-adrenoceptors in the pithed rat. J Pharmacol Exp Ther 1984; 230: 595-600.